Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury (The ELAIN-Trial): Study protocol for a randomized controlled trial

Zarbock, A and Gerß, J and Van Aken, H and Boanta, A and Kellum, JA and Meersch, M (2016) Early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury (The ELAIN-Trial): Study protocol for a randomized controlled trial. Trials, 17 (1).

[img]
Preview
PDF
Published Version
Available under License : See the attached license file.

Download (1MB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)

Abstract

© 2016 Zarbock et al. Background: Acute kidney injury remains a common complication in critically ill patients and despite multiple trials and observational studies, the optimal timing for initiation of renal replacement therapy is still unclear. The early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury (ELAIN) study is a randomized, single-center, prospective, two-arm, parallel group trial to reduce mortality in patients with severe acute kidney injury. We describe the study design and discuss aspects of the need for a trial in this patient cohort. Methods/design: Our plan is to randomize critically ill patients with acute kidney injury to 'early' or 'late' initiation of renal replacement therapy according to stage 2 and 3 of the KDIGO classification using a specific trial protocol. We plan to guide data collection and analysis using pre-existing definitions and testing. The primary endpoint is overall survival in a 90-day follow-up period. Secondary endpoints include 28-day, 60-day, 90-day and 1-year all-cause mortality, recovery of renal function, ICU and hospital length-of-stay. The primary analysis will be an intention-to-treat analysis; secondary analyses include treated analyses. We will also specify rules for handling data and determining outcome. Discussion: Several challenges for study design and execution can be seen in our trial, and it should generate results that will inform and influence the practice of renal replacement therapy in critically ill patients with acute kidney injury. Trial registration: German Clinical Trials Register: DRKS00004367 (www.germanctr.de); 28 May 2013.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Zarbock, A
Gerß, J
Van Aken, H
Boanta, A
Kellum, JAkellum@pitt.eduKELLUM0000-0003-1995-2653
Meersch, M
Date: 18 March 2016
Date Type: Publication
Journal or Publication Title: Trials
Volume: 17
Number: 1
DOI or Unique Handle: 10.1186/s13063-016-1249-9
Schools and Programs: School of Medicine > Critical Care Medicine
Refereed: Yes
Date Deposited: 23 Aug 2016 13:33
Last Modified: 04 Feb 2019 15:57
URI: http://d-scholarship.pitt.edu/id/eprint/28701

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com


Actions (login required)

View Item View Item